AUG 14, 2015 10:28 AM PDT

Kick the Habit

WRITTEN BY: Kerry Evans
Nearly 6 million people die every year from tobacco-related illness, but breaking the addiction is easier said than done.  Current smoking cessation therapies include the nicotine receptor agonist varenicline, the antidepressant bupropion, and various nicotine replacement therapies (gums, patches, and lozenges). However, more effective aids are needed, because only 15-30% of people who use these therapies remain tobacco-free in the long-term.

Tobacco-related illness kills nearly 6 million annually.
One alternative to drug-based therapy is a "nicotine vaccine".     In fact, a number of nicotine vaccines are in clinical trials, but show varied success when compared to placebos.

Researchers at The Scripps Research Institute (TSRI) are taking a different approach.     They knew a number of microorganisms were capable of degrading tobacco waste, and one bacterium, Pseudomonas putida, is extremely good at it.  
 


“The bacterium is like a little Pac-Man”, says Kim Janda, professor of chemistry at TSRI, “it goes along and eats nicotine”.


Non-pathogenic P. putida uses a number of enzymes to degrade nicotine to fumaric acid.  Song Xue, a graduate student at TSRI, investigated the enzyme NicA2 for its safety and efficacy as a smoking cessation drug, and the preliminary data appears quite promising.

When Xue and colleagues combined serum from mouse blood, nicotine, and NicA2, the half-life of nicotine dropped from 2 to 3 hours to between 9 and 15 minutes. On top of that, NicA2 remained stable in serum, produced no toxic metabolites, and proved to be heat stable for up to 3 weeks.  These are all signs that NicA2 could one day help people kick the tobacco habit.



Sources: Journal of the American Chemical Society, The Scripps Research Institute, Tech Times
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
NOV 13, 2019
Genetics & Genomics
NOV 13, 2019
A Major Step Toward a Vaccine for Severe Malaria
Scientists have now learned more about malaria proteins and the antibodies that combat them....
NOV 25, 2019
Microbiology
NOV 25, 2019
Salmonella is Getting Meaner
Salmonella infections are growing increasingly resistant to antibiotics, and are beginning to affect more adults instead of just children and the elderly....
DEC 01, 2019
Microbiology
DEC 01, 2019
Some Antacids Appear to Increase the Risk of Gastroenteritis
Proton pump inhibitors (PPIs) are drugs for heartburn relief; they can reduce stomach acid levels....
DEC 06, 2019
Microbiology
DEC 06, 2019
Hybrid Antibiotic Can Destroy Dangerous Staph Biofilms
When staph begins to grow on medical devices like implants used on wounds, artificial joints, or catheters, they can cause chronic, serious infections....
DEC 15, 2019
Microbiology
DEC 15, 2019
Neurons in the Gut Can Detect Salmonella & Protect Against Infection
Nerve cells act as critical sensors for the human body, and now scientists have found that they have another role in the small intestine....
JAN 21, 2020
Microbiology
JAN 21, 2020
New Coronavirus is Spreading in China
In late December, health officials in China notified WHO that pneumonia with an unknown cause was sickening people....
Loading Comments...